Bing

SEARCH HISTORY

That’s not a surprise. In our initial report, we classified TrovaGene as an ultra-high-risk stock, said to expect a volatile run, and recommended investors be willing to hold the shares for at least two years to ride out the big swings that almost always ...
Money Morning · 10/4/2014
Keryx Biopharmaceuticals, Inc. (KERX) announced second-quarter financial results for ... On a year-to-date basis the stock has returned over 25%.
bidnessetc.com · 8/7/2014
Several Biotech Stocks Indicating A Macro Short Strategy (Seeking Alpha) CEO Greg Madison commented, “With the first full quarter of launch behind us, we have made great progress in securing formulary wins for Auryxia™ (ferric citrate), which is a ...
Benzinga · 5/5/2015
More from Bing News
CHICAGO, June 11, 2015 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for UA, TYL, FUEL, KERX and JCP. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by …
The Business Journal · 6/11/2015
The Baupost Group raised its position in Keryx Biopharmaceuticals (KERX) that accounted for 4.38% of the fund ... The position was initiated in 1Q14. The stock price is up ~ 26% year-to-date, as of November 28. Keryx Biopharmaceuticals is a ...
Market Realist · 12/4/2014
On January 31st Dino in California asked about Keryx Biopharmaceuticals, KERX, a tiny biotech stock. After digging through reports and more, Cramer said "On January 28th, Keryx wowed the medical community with some astonishing data on an oral drug …
CNBC · ByLee Brodie · 3/8/2013
NEW YORK, NY (MMD Newswire) April 20, 2012 -- Ron Bentsur purchased 19,100 shares of Keryx Biopharmaceuticals Inc stock, or $24,773 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred on April 18, 2012. After …
MMD Newswire · 4/20/2012
“Catalysts can drive an investment up or down. A favorable event can push a stock to new heights, but if events turn sour, the exit for these shares can be very narrow and very crowded. Let’s take the example of a classic investment catalyst: adverse ...
Trefis · 2/11/2013
Large percentage drops always require that the stock post even larger percentage gains from the low in order to recover the old price point, and for KERX that means the stock would have to gain 96.60% to get back to the 52-week high. For a move like that ...
Market News Video · 6/5/2015
January 21, 2015 19:53 ET | Source: Keryx Biopharmaceuticals, Inc. NEW YORK, Jan. 21, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the pricing of an underwritten public offering of common stock
GlobeNewswire · 1/22/2015